Through analyzing the expression of immune checkpoints in tumor and the effect of checkpoints inhibitors, researchers found a positive correlation between immune checkpoints (such as PD-L1) over-expression and the treatment response in lung cancer and melanoma [11, 12]. This evidence concerns the gene CD274 and lung cancer.